Study evaluating safety, tolerability, PK/PD of surovatamig in adult RA or SLE participants

Trial Identifier: D740AC00001
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: June 2028
Study Completion Date: June 2028
Condition: Rheumatoid Arthritis; Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Birtinya, AU, 4575
AU Clayton, AU, 3168
BE ANTWERPEN, BE, 2020
BR Porto Alegre, BR, 90035-903
CN Beijing, CN, 100034
CN Nanjing, CN, 210008
DE Bonn, DE, 53127
DE München, DE, D-80336
ES Barcelona, ES, 08025
ES Córdoba, ES, 14004
UA Kyiv, UA, 04050
UA Ternopil, UA, 46002
UA Vinnytsia, UA, 21018
US, CA Fullerton, CA, US, 92835
US, TX Allen, TX, US, 75013